Bella Gorbatcheva

Bella has over 20 years of experience in drug discovery and global development, strategic outsourcing/partnerships and project/program management focusing on oncology/immuno-oncology and rare neuromuscular diseases.

She held various roles across academia and the pharmaceutical/biotech sector (Millennium Pharmaceuticals, Novartis, Merck KGaA). Most recently, she supported the Translational Sciences leadership team for monitoring pharmacology, toxicology and clinical biomarker development functions at Sarepta Therapeutics and provided project management support to the Sarepta Program Office in advancing the Duchenne Muscular Dystrophy RNA-targeted therapeutic programs, from early development to marketed stages.